Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Identify which cards provide flexible rewards without any fees. Compare your options for optimal rewards.
26,016 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Rocket Lab stock is catching strong momentum this week. We break down the key drivers behind the rally, what it means...
As Zoom prepares for 2026, investors want to know how the company will grow revenue, expand margins, and win with AI....
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
SpaceX is the talk of Wall Street, but a rush to buy at the IPO could be reckless. This guide explains why waiting fo...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
This week brings four major earnings reports that could reveal trends in consumer spending, AI demand, and corporate ...
Through the first half of 2026, mega funds over $1B captured about 72% of all VC capital raised, while first-time man...
A new era at the Fed could be starting, sparked by a bold move from a hypothetical chair. This piece breaks down what...
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...